References
- Heazell AEP, Siassakos D, Blencowe H, et al. Stillbirths: economic and psychosocial consequences. Lancet 2016;387:604–16.
- Lawn JE, Blencowe H, Waiswa P, et al. Stillbirths: rates, risk factors, and acceleration towards 2030. Lancet 2016;387:587–603.
- Flenady V, Wojcieszek AM, Middleton P, et al. Stillbirths: recall to action in high-income countries. Lancet 2016;387:691–702.
- De Bernis L, Kinney MV, Stones W, et al. Stillbirths: ending preventable deaths by 2030. Lancet 2016;387:703–16.
- Flenady V, Middleton P, Smith GC, et al. Stillbirth: the way forward in high-income countries. Lancet 2011;377:1703–17.
- Froen JF, Cacciatore J, McClure EM, et al. Stillbirth: why they matter. Lancet 2011;377:1353–66.
- Twenty-sixth Report of Maternal, Perinatal and Infant Mortality committee. Adelaide, South Australia: Government of South Australia, SA health. 2011.
- Zhou A, Dekker GA, Lumbers ER, et al. The association of maternal ACE A11860G with small for gestational age babies is modulated by the environment and by fetal sex: a multicentre prospective case–control study. Mol Hum Reprod 2013;19:618–27.
- de Graaff EC, Wijs LA, Leemaqz S, et al. Risk factors for stillbirth in a socio-economically disadvantaged urban Australian population. J Matern Fetal Neonatal Med 2017;30:17–22.
- Gardosi J. Customised assessment of fetal growth potential: implications for perinatal care. Arch Dis Child Fetal Neonatal Ed 2012;97:F314–F317.
- van Eerd EA, Roex AJ, Nikpoor P, et al. Adverse perinatal outcome and maternal risk factors in population versus customized defined SGA babies. J Matern Fetal Neonatal Med 2012;25:369–73.
- Fenech M, Aitken C, Rinaldi J. Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults. Carcinogenesis 1998;19:1163–71.
- Frøen JF, Gardosi JO, Thurmann A, et al. Restricted fetal growth in sudden intrauterine unexplained death. Acta Obstet Gynecol Scand 2004;83:801–7.
- Gardosi J, Kady SM, McGeown P, et al. Classification of stillbirth by relevant condition at death (ReCoDe): population based cohort study. BMJ 2005;331:1113–7.
- Figueras F, Gardosi J. Intrauterine growth restriction: new concepts in antenatal surveillance, diagnosis, and management. AJOG 2011;204:288–300.
- Baschat A. Fetal responses to placental insufficiency: an update. BJOG 2004;11:1031–41.
- Goldenberg RL, McClure EM, Saleem S, et al. Infection-related stillbirths. Lancet 2010;375:1482–90.
- Khong. Y. The placenta in stillbirth. Curr Diag Pathol 2006;12:161–72.
- Pinar H, Goldenberg RL, Koch MA, et al. Placental findings in singleton stillbirths. Obstet Gynecol 2014;123:325–36.
- Varli I H, Petersson K, Kublickas M, et al. Both acute and chronic placental inflammation are overrepresented in term stillbirths: a case-control study. Infect Dis Obstet Gynecol 2012;2012:Article ID. DOI: 10.1155/2012/293867. 293867.
- Monari F, Gabrielli L, Gargano G, et al. Fetal bacterial infections in antepartum stillbirth: a case series. Early Hum Dev 2013;89:1049–54.
- Kessous R, Weintraub AY, Sergienko R, et al. Bacteruria with group-B streptococcus: is it a risk-factor for adverse pregnancy outcomes? J Matern Fetal Neonatal Med 2012;25:1983–6.
- Clifford V, Garland SM, Grimwood K. Prevention of neonatal group B streptococcus disease in the 21st century. J Paediatr Child Healt 2012;48:808–15.
- Flenady V, Koopmans L, Middleton P, et al. Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet 2011; 377:1331–40.
- Ananth CV, Berkowitz GS, Savitz DA. Placental abruption and adverse perinatal outcomes. JAMA 2003;282:1646–51.
- Budde MP, De Lange TE, Dekker GA, et al. Risk factors for placental abruption in a socia-economically disadvantaged region. J Matern Fetal Neonatal Med 2007;20:687–93.
- Rey E, Kahn SR, David M, et al. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003;361:901–08.
- Kupferminc MJ. Thrombophilia and pregnancy. Reprod Biol Endocrinol 2003;1:111.
- Tikkanen M, Nuutila M, Hiilesmaa V, et al. Clinical presentation and risk factors of placental abruption. Acta Obstet Gynecol Scand 2006;85:700–05.
- O’Leary C, Jacoby P, D’Antoine H, et al. Heavy prenatal alcohol exposure and increased risk of stillbirth. BJOG 2012;119:945–52.
- McCarthy FP, O'Keeffe LM, Khashan AS, et al. Association between maternal alcohol consumption in early pregnancy and pregnancy outcomes. Obstet Gynecol. 2013;122:830–7.
- Kennare R, Heard A, Chan A. Substance use during pregnancy: risk factors and obstetric and perinatal outcomes in South Australia. Aus N Z J Obstet Gynaecol 2005;45:220–5.
- Varner MW, Silver RM, Hogue CJ, et al. Association between stillbirth and illicit drug use and smoking during pregnancy. Obstet gynecol 2014;123:113–25.
- Viteri OA, Mendez-Figueroa H, Pedroza C, et al. Relationship between self-reported maternal substance abuse and adverse outcomes in the premature newborn. Am J Perinatol 2016;33:165–71.
- Marsh CA, Hecker E. Maternal obesity and adverse reproductive outcomes: reducing the risk. Obstet Gynecol Surv 2014;69:622–8.